| 941 |
LENMAKS 10 |
LENVATINIB MESYLATE 10 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE REFRACTORY DIFFERENTIATED THYROID CANCER |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1241/24 |
2024-11-19 |
2029-11-18 |
View |
| 942 |
LENMAKS 4 |
LENVATINIB MESYLATE 4 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE REFRACTORY DIFFERENTIATED THYROID CANCER |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1237/24 |
2024-11-13 |
2029-11-12 |
View |
| 943 |
REGOMAKS |
REGORAFENIB 40 MG |
FILM COATED TABLET |
BOTTLE |
COLORECTAL CANCER, GASTROINTESTINAL STROMAL TUMORS, HEPATOCELLULAR CARCINOMA |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1242/24 |
2024-11-19 |
2029-11-18 |
View |
| 944 |
TAF-MAKS |
TENOFOVIR ALAFENAMIDE 25 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION IN ADULTS WITH COMPENSATED LIVER DISEASE |
Yes |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1243/24 |
2024-11-19 |
2029-11-18 |
View |
| 945 |
BRIGAMAKS |
BRIGATINIB 90 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE METASTATIC NON - SMALL CELL LUNG CANCER WHOSE DISEASE HAS PROGRESSED ON OR ARE TOLERANT TO CRIZOTINIB |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1240/24 |
2024-11-19 |
2029-11-18 |
View |
| 946 |
CRIZOMAKS |
CRIZOTONIB 250 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER THAT IS ANAPLASTIC LYMPHOMA KINASE POSITIVE |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1238/24 |
2024-11-13 |
2029-11-12 |
View |
| 947 |
SOTORMAKS |
SOTORASIB 120 MG |
TABLET |
BLISTERPACK |
FOR THE TREATMENT OF ADULT PATIENTS WITH KRAS G12C-MUTATED LOCALLY ADVANCED OR METASTATIC NON SMALL CELL LUNG CANCER, WHO HAVE RECEIVED AT LEAST ONE PRIOR SYSTEMIC THERAPY |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1236/24 |
2024-11-13 |
2029-11-12 |
View |
| 948 |
CABOMAKS 20 |
CABOZANTINIB 20 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) WHO HAVE BEEN PREVIOUSLY TREATED WITH SORAFENIB |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1235/24 |
2024-11-13 |
2029-11-12 |
View |
| 949 |
PHOLENVA 4 |
LENVATINIB 4 MG |
CAPSULE |
BLISTERPACK |
FOR THE TREATMENT OF PATIENTS WITH LOCALLY RECURRENT OR METASTATIC, PROGRESSIVE, RADIOACTIVE IODINE REFRACTORY DIFFERENTIATED THYROID CANCER |
No |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
02 L 0823/20 |
2023-08-29 |
2026-08-28 |
View |
| 950 |
ETHANOL-GLYCERINE |
GLYCERINE 50 ML, ETHANOL 70 %/100 ML |
SOLUTION |
BLISTERPACK |
TREATMENT OF TINNITUS |
No |
FACTORY NO.2 |
FACTORY No.2 |
LAO PDR |
CERTIFICATE RELEASED |
01 L 0841/21 |
2024-07-29 |
2027-07-28 |
View |
